Pricing Fuzeon - Cost of Innovation?
|
|
ICMR HOME | Case Studies Collection
To download Pricing Fuzeon - Cost of Innovation? case study
(Case Code: MKTG121) click on the button below, and select the case from the list of available cases:
» Marketing Case Studies
» Marketing Management Short Case Studies
» View Detailed Pricing Info
» How To Order This Case
» Business Case Studies
» Case Studies by Area
» Case Studies by Industry
» Case Studies by Company
Please note:
This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.
Chat with us
Please leave your feedback
|
Case Details:
|
Price: |
| Case Code |
: |
MKTG121 |
For delivery in electronic format: Rs.
500;
For delivery through courier (within India): Rs. 500 + Shipping & Handling Charges extraThemes
|
| Case Length |
: |
28 Pages |
| Period |
: |
1990 - 2006 |
| Pub Date |
: |
2006 |
| Teaching Note |
: |
Available |
| Organization |
: |
Trimeris Inc. and Roche |
| Industry |
: |
Pharmaceutical and Healthcare |
| Countries |
: |
USA, Europe |
Abstract:
|
This case is about Fuzeon, an innovative 'first of its kind' drug used for the treatment of HIV/AIDS. The drug was developed by Trimeris and marketed by Roche.
Though Fuzeon was considered a 'breakthrough' drug, its price was very high. The case discusses the reasons as to why the company had decided to price the drug at a premium.
Fuzeon's pricing also raised ethical concerns as it was priced out of the reach of people who needed it the most. The case also discusses the challenges faced by Trimeris and Roche in marketing this drug.
|
|
Issues:
• Understand the issues in drug pricing, particularly for anti-AIDS drugs.
• Understand the risks that pharmaceutical companies face in developing and launching a new product in the market.
• Understand the challenges faced by companies in marketing a new product at a premium price.
Contents:
Keywords:
Trimeris Inc., Roche, Fuzeon, Fusion Inhibitor Technology, Anti - AIDS / HIV drugs, New Product Development, Pharmaceutical Healthcare, Product Pricing, Marketing Management, Antiretroviral Drugs, Research and Development, ACT UP/NY, Clinical Trials, New Product launch, Distribution Network
Pricing Fuzeon - Cost of Innovation?
- Next Page>>
|
|
